Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
País/Região como assunto
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Mar Pollut Bull ; 166: 112187, 2021 May.
Artigo em Inglês | MEDLINE | ID: mdl-33639379

RESUMO

Millions of tons of plastic enter the environment every year, where much of it concentrates in environmental sinks such as tidal marshes. With prior studies documenting harm to marine fauna caused by this plastic pollution, the need to understand how this novel type of pollution affects estuarine fauna is great. Yet, research on the fate and uptake of plastic pollutants in estuarine ecosystems is sparse. Therefore, we quantified plastic prevalence and ingestion by two species of resident marsh bird, Clapper Rails (Rallus crepitans) and Seaside Sparrows (Ammospiza maritima), in coastal marsh ecosystems within Mississippi. We detected microplastics (plastics smaller than 5 mm) in 64% of marsh sediment samples, 83% of Clapper Rail and 69% of Seaside Sparrow proventriculus samples. Dominant types of microplastics detected in sediment and bird samples were fibers. This study provides the first evidence of microplastic ingestion by marsh birds and its distribution in coastal marshes within Mississippi.


Assuntos
Poluentes Químicos da Água , Áreas Alagadas , Animais , Aves , Ingestão de Alimentos , Ecossistema , Monitoramento Ambiental , Microplásticos , Mississippi , Plásticos , Poluentes Químicos da Água/análise
2.
Vaccine ; 28(12): 2465-71, 2010 Mar 11.
Artigo em Inglês | MEDLINE | ID: mdl-20064479

RESUMO

To evaluate the potential economic value of a Staphylococcus aureus vaccine for pre-operative orthopedic surgery patients, we developed an economic computer simulation model. At MRSA colonization rates as low as 1%, a $50 vaccine was cost-effective [or=30%, and a $100 vaccine at vaccine efficacy >or=70%. High MRSA prevalence (>or=25%) could justify a vaccine price as high as $1000. Our results suggest that a S. aureus vaccine for the pre-operative orthopedic population would be very cost-effective over a wide range of MRSA prevalence and vaccine efficacies and costs.


Assuntos
Staphylococcus aureus Resistente à Meticilina/imunologia , Cuidados Pré-Operatórios/economia , Cuidados Pré-Operatórios/métodos , Infecções Estafilocócicas/prevenção & controle , Vacinas Antiestafilocócicas/economia , Vacinas Antiestafilocócicas/imunologia , Infecção da Ferida Cirúrgica/prevenção & controle , Análise Custo-Benefício , Humanos , Modelos Estatísticos , Ortopedia , Infecções Estafilocócicas/economia , Infecção da Ferida Cirúrgica/economia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA